COCO
Vita CocoCAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
This should remain a tentative monitoring memo, not a standard-conviction call. Primary-source evidence is solid, but recent news flow is sparse, peer fit is loose, and the deterministic prior is negative across 5d/20d/60d/120d horizons with only mid-level evidence quality (0.54) and catalyst density (0.50), while forward proof for the 2026 bridge is still limited.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
John Leahy said he will not stand for reelection at the June 3, 2026 annual meeting, and the company said the decision was for personal reasons with no disagreement on operations, policies, or practices, which suggests limited near-term operating impact despite a minor governance overhang [#8-K-2026-04-10].
The February 18, 2026 earnings release guided to 2026 net sales of $680-$700 million, gross margin of about 38%, and adjusted EBITDA of $122-$128 million after 2025 net sales rose to $610 million and adjusted EBITDA to $98 million; with no 2026 reported quarter yet in the packet, this remains a monitoring setup that needs multiple quarterly checkpoints to confirm the tariff, pricing, and private-label bridge [#PR-2026-02-18].
Vita Coco extended its Century Pacific manufacturing agreement to December 31, 2030 and described a six-country factory network, which supports capacity and sourcing flexibility, but the 10-K still shows coconut water at 96% of revenue, Customer A and Customer B at 19% and 25% of 2025 sales, and Suppliers A/B/C at 18%, 13%, and 10% of purchases, keeping execution risk elevated [#8-K-2025-06-12] [#10-K-2026-02-18].
Recommendation
No formal recommendation provided.

